Fratzl-Zelman N - Search Results

1

Bone Matrix Mineralization and Response to Burosumab in Adult Patients With X-Linked Hypophosphatemia: Results From the Phase 3, Single-Arm International Trial.

Fratzl-Zelman N, Hartmann MA, Gamsjaeger S, Rokidi S, Paschalis EP, Blouin S, Zwerina J. Fratzl-Zelman N, et al. J Bone Miner Res. 2022 Sep;37(9):1665-1678. doi: 10.1002/jbmr.4641. Epub 2022 Aug 10. J Bone Miner Res. 2022. PMID: 35775373 Free article. Clinical Trial.

2

Matrix mineralization in MC3T3-E1 cell cultures initiated by beta-glycerophosphate pulse.

Fratzl-Zelman N, Fratzl P, Hörandner H, Grabner B, Varga F, Ellinger A, Klaushofer K. Fratzl-Zelman N, et al. Bone. 1998 Dec;23(6):511-20. doi: 10.1016/s8756-3282(98)00139-2. Bone. 1998. PMID: 9855459

3

Orientation of mineral crystallites and mineral density during skeletal development in mice deficient in tissue nonspecific alkaline phosphatase.

Tesch W, Vandenbos T, Roschgr P, Fratzl-Zelman N, Klaushofer K, Beertsen W, Fratzl P. Tesch W, et al. J Bone Miner Res. 2003 Jan;18(1):117-25. doi: 10.1359/jbmr.2003.18.1.117. J Bone Miner Res. 2003. PMID: 12510812 Free article.

4

Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats.

Valenta A, Roschger P, Fratzl-Zelman N, Kostenuik PJ, Dunstan CR, Fratzl P, Klaushofer K. Valenta A, et al. Bone. 2005 Jul;37(1):87-95. doi: 10.1016/j.bone.2005.03.013. Bone. 2005. PMID: 15869920

5

Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta.

Weber M, Roschger P, Fratzl-Zelman N, Schöberl T, Rauch F, Glorieux FH, Fratzl P, Klaushofer K. Weber M, et al. Bone. 2006 Sep;39(3):616-22. doi: 10.1016/j.bone.2006.02.071. Epub 2006 Apr 27. Bone. 2006. PMID: 16644299 Clinical Trial.

6

Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.

Fratzl P, Roschger P, Fratzl-Zelman N, Paschalis EP, Phipps R, Klaushofer K. Fratzl P, et al. Calcif Tissue Int. 2007 Aug;81(2):73-80. doi: 10.1007/s00223-007-9039-8. Calcif Tissue Int. 2007. PMID: 17612779

7

Collagen cross-linking influences osteoblastic differentiation.

Turecek C, Fratzl-Zelman N, Rumpler M, Buchinger B, Spitzer S, Zoehrer R, Durchschlag E, Klaushofer K, Paschalis EP, Varga F. Turecek C, et al. Calcif Tissue Int. 2008 May;82(5):392-400. doi: 10.1007/s00223-008-9136-3. Epub 2008 May 17. Calcif Tissue Int. 2008. PMID: 18488133

8

Effects of tumor-induced osteomalacia on the bone mineralization process.

Nawrot-Wawrzyniak K, Varga F, Nader A, Roschger P, Sieghart S, Zwettler E, Roetzer KM, Lang S, Weinkamer R, Klaushofer K, Fratzl-Zelman N. Nawrot-Wawrzyniak K, et al. Calcif Tissue Int. 2009 Apr;84(4):313-23. doi: 10.1007/s00223-009-9216-z. Epub 2009 Feb 14. Calcif Tissue Int. 2009. PMID: 19219382 Free article.

9

Normative data on mineralization density distribution in iliac bone biopsies of children, adolescents and young adults.

Fratzl-Zelman N, Roschger P, Misof BM, Pfeffer S, Glorieux FH, Klaushofer K, Rauch F. Fratzl-Zelman N, et al. Bone. 2009 Jun;44(6):1043-8. doi: 10.1016/j.bone.2009.02.021. Epub 2009 Mar 4. Bone. 2009. PMID: 19268565

10

Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after long-term alendronate treatment: qBEI and sSAXS data from the fracture intervention trial long-term extension (FLEX).

Roschger P, Lombardi A, Misof BM, Maier G, Fratzl-Zelman N, Fratzl P, Klaushofer K. Roschger P, et al. J Bone Miner Res. 2010 Jan;25(1):48-55. doi: 10.1359/jbmr.090702. J Bone Miner Res. 2010. PMID: 19580465 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters